These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33006693)

  • 41. A case of radical resection for brain metastases of pancreatic cancer after curative chemotherapy for para-aortic lymph node metastases.
    Utsunomiya T; Funamizu N; Ozaki E; Tamura K; Sakamoto K; Ogawa K; Kusakabe K; Suehiro S; Yamashita D; Kurata M; Kitazawa R; Takada Y
    Surg Case Rep; 2022 Jun; 8(1):108. PubMed ID: 35666369
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.
    Labori KJ; Bratlie SO; Andersson B; Angelsen JH; Biörserud C; Björnsson B; Bringeland EA; Elander N; Garresori H; Grønbech JE; Haux J; Hemmingsson O; Liljefors MG; Myklebust TÅ; Nymo LS; Peltola K; Pfeiffer P; Sallinen V; Sandström P; Sparrelid E; Stenvold H; Søreide K; Tingstedt B; Verbeke C; Öhlund D; Klint L; Dueland S; Lassen K;
    Lancet Gastroenterol Hepatol; 2024 Mar; 9(3):205-217. PubMed ID: 38237621
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent progress in multidisciplinary treatment for patients with esophageal cancer.
    Watanabe M; Otake R; Kozuki R; Toihata T; Takahashi K; Okamura A; Imamura Y
    Surg Today; 2020 Jan; 50(1):12-20. PubMed ID: 31535225
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study).
    Heinrich S; Pestalozzi B; Lesurtel M; Berrevoet F; Laurent S; Delpero JR; Raoul JL; Bachellier P; Dufour P; Moehler M; Weber A; Lang H; Rogiers X; Clavien PA
    BMC Cancer; 2011 Aug; 11():346. PubMed ID: 21831266
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neoadjuvant chemoradiation therapy in patients with surgically treated esophageal cancer.
    Vermund H; Pories WJ; Hillard J; Wiley AL; Youngblood R
    Acta Oncol; 2001; 40(5):558-65. PubMed ID: 11669326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Change in neoadjuvant chemotherapy could alter the prognosis of patients with pancreatic adenocarcinoma: A case report.
    Meyer A; Carvalho BJ; Medeiros KA; Pipek LZ; Nascimento FS; Suzuki MO; Munhoz JV; Iuamoto LR; Carneiro-D'Alburquerque LA; Andraus W
    World J Clin Cases; 2021 May; 9(14):3418-3423. PubMed ID: 34002153
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preoperative chemotherapy for resectable thoracic esophageal cancer.
    Malthaner R; Fenlon D
    Cochrane Database Syst Rev; 2001; (1):CD001556. PubMed ID: 11279723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel +/- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma (the STEREOPAC trial): study protocol for a randomised comparative multicenter phase II trial.
    Bouchart C; Navez J; Borbath I; Geboes K; Vandamme T; Closset J; Moretti L; Demetter P; Paesmans M; Van Laethem JL
    BMC Cancer; 2023 Sep; 23(1):891. PubMed ID: 37735634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial.
    von Döbeln GA; Klevebro F; Jacobsen AB; Johannessen HO; Nielsen NH; Johnsen G; Hatlevoll I; Glenjen NI; Friesland S; Lundell L; Yu J; Nilsson M
    Dis Esophagus; 2019 Feb; 32(2):. PubMed ID: 30137281
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metastasized pancreatic carcinoma with neoadjuvant FOLFIRINOX therapy and R0 resection.
    Schneitler S; Kröpil P; Riemer J; Antoch G; Knoefel WT; Häussinger D; Graf D
    World J Gastroenterol; 2015 May; 21(20):6384-90. PubMed ID: 26034375
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Are We Sure that Adjuvant Chemotherapy is the Best Approach for Resectable Pancreatic Cancer? Are We in the Era of Neoadjuvant Treatment? A Review of Current Literature.
    Oneda E; Zaniboni A
    J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31717439
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Study protocol for a prospective, open-label, single-arm, phase II study on the combination of tislelizumab, nab-paclitaxel, gemcitabine, and concurrent radiotherapy as the induction therapy for patients with locally advanced and borderline resectable pancreatic cancer.
    Lu C; Zhu Y; Kong W; Yang J; Zhu L; Wang L; Tang M; Chen J; Li Q; He J; Li A; Qiu X; Gu Q; Chen D; Meng F; Liu B; Qiu Y; Du J
    Front Oncol; 2022; 12():879661. PubMed ID: 36059628
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Case Report: Triple Primary Malignant Tumors of the Esophagus, Stomach, and Colon in a Patient With Genetic Analysis.
    Zhan X; He L; Song K; Cao S; Meng E; Wang Y
    Front Genet; 2021; 12():676497. PubMed ID: 34306021
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Postoperative adjuvant chemotherapy in rectal cancer operated for cure.
    Petersen SH; Harling H; Kirkeby LT; Wille-Jørgensen P; Mocellin S
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD004078. PubMed ID: 22419291
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
    Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
    BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Resectable adenocarcinoma developing in the remnant pancreas 7 years after partial pancreatoduodenectomy for invasive ductal adenocarcinoma of the pancreas: a case report.
    Frei L; Stieger R; Bayerl C; Breitenstein S; Staerkle RF
    J Med Case Rep; 2017 Jul; 11(1):194. PubMed ID: 28716115
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neoadjuvant chemoradiation for locally advanced resectable carcinoma of the esophagus: A single-center experience from India with a brief review of the literature.
    Krishnamurthy A; Mohanraj N; Radhakrishnan V; John A; Selvaluxmy G
    Indian J Cancer; 2017; 54(4):646-651. PubMed ID: 30082551
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Locally advanced rectal cancer receiving total neoadjuvant therapy combined with nivolumab: a case report and literature review.
    Mori R; Uemura M; Sekido Y; Hata T; Ogino T; Takahashi H; Miyoshi N; Mizushima T; Doki Y; Eguchi H
    World J Surg Oncol; 2022 May; 20(1):166. PubMed ID: 35619103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A case report-neoadjuvant chemoradiotherapy with combination of S-1 and gemcitabine in a patient with locally advanced pancreatic cancer].
    Watanabe F; Honda G; Kurata M; Tsuruta K; Tokashiki T; Funada N
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2430-2. PubMed ID: 20037446
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A case of pancreatic head cancer with Trousseau's syndrome treated with radical resection and anticoagulant therapy.
    Kitahama T; Otsuka S; Sugiura T; Ashida R; Ohgi K; Yamada M; Uesaka K
    Surg Case Rep; 2023 Jan; 9(1):6. PubMed ID: 36633733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.